Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic ...
Add Yahoo as a preferred source to see more of our stories on Google. Kendrick Perkins held back after heated altercation at ...
7hon MSN
After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses
The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.
A pill that doubles life expectancy in patients with pancreatic cancer has been hailed as the biggest breakthrough for ...
Revolution Medicines’ RVMD Phase 3 daraxonrasib data in metastatic pancreatic cancer cut death risk 60% and doubled ...
Johnson & Johnson’s PROTEUS Phase 3 trial shows apalutamide + hormone therapy before/after surgery improves outcomes in ...
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...
Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate ...
An experimental pill helped people with one of the most deadly cancers in the world live longer, researchers reported this ...
inews.co.uk on MSN
Why this new pill for a deadly cancer has doctors excited
The results of a clinical trial could signal a breakthrough in treating pancreatic cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results